Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06969287 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

Study acronym: MD FluNCS
StatusRecruiting
PhasePhase 3
Started2026-04-06
View on ClinicalTrials.gov ↗
The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine to mitigate postoperative delirium risk in geriatric patients undergoing non-cardiac non-intracranial surgery.

Amendment record

Amended 6 times since 2025-05-08; most recent filed 2026-04-24. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2026-04-24
Amendment Study Status, Sponsor/Collaborators, Contacts/Locations v6
2026-04-17
Amendment Study Status, Contacts/Locations v5
2026-02-25
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
2025-12-22
Amendment Study Status v3
2025-10-01
Amendment Study Status, Outcome Measures v2
2025-07-14
Amendment Study Status v1
2025-05-08
Original filing
Trial Details
NCT Number NCT06969287
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute on Aging (NIA)
Conditions Delirium, Surgery-Complications
Enrollment 46 participants
Start Date 2026-04-06
Primary Completion 2027-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-29